Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04432857
Title AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adlai Nortye Biopharma Co., Ltd.
Age Groups: senior | adult
Covered Countries USA | FRA

No variant requirements are available.